Anna Parks

13PUBLICATIONS
24CO-AUTHORS
AutoimmunityEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyMemory and attention
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 20, 2026
Prospective evaluation of systemic coagulation function during anti-amyloid monoclonal antibody therapy in Alzheimer's disease.

|Mar 26, 2026
Comparative Effectiveness of Oral Anticoagulants and Home Time After Venous Thromboembolism in Frail and Non-Frail Older Adults.

Chan Mi Park, Sandra Shi, Xiecheng Chen

|Jan 07, 2026
Cancer-Associated Thrombosis: Surveying Patients' Awareness and Education Needs.

Andrew Bueno, Ishan J Tatake, Ang Li

|Dec 29, 2025
Risk of New Indications for Anticoagulants and Thrombolytics in People With Cognitive Impairment: Implications for Anti-Amyloid Therapy.

Anna L Parks, Jacquelyn M Lykken, Meghan L Rieu-Werden

|Jul 18, 2025
The clot cases conference: a proposed model to enhance multidisciplinary thrombosis care.

Anna L Parks, Stephen L Jenkins, Sara R Vazquez

|Apr 10, 2025
A qualitative study of people with Alzheimer's disease in a memory clinic considering lecanemab treatment.

Anna L Parks, Ayush Thacker, Daniel Dohan

Pageof 3

Frequent Collaborators

3 joint publications

Margaret C Fang

1 joint publications

Swetha Kambhampati

1 joint publications

Amanda Bertram

1 joint publications

W John Boscardin